They have been doing studies for a couple years no
Post# of 148305
Quote:
These results together provide the basis for the potential use of leronlimab as a new therapeutic modality for human solid tumors expressing CCR5.
Quote:
These results together provide the basis for the potential use of leronlimab as a new therapeutic modality for human solid tumors expressing CCR5.